COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe - EPA:CRI - FR0000130692 - Common Stock
9.66 EUR
0 (0%)
CRI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 15 industry peers in the Industrial Conglomerates industry. CRI may be in some trouble as it scores bad on both profitability and health. CRI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year CRI was profitable.
CRI had a positive operating cash flow in the past year.
Of the past 5 years CRI 4 years were profitable.
In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of CRI (0.26%) is worse than 66.67% of its industry peers.
The Return On Equity of CRI (0.96%) is worse than 66.67% of its industry peers.
The Return On Invested Capital of CRI (5.19%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CRI is below the industry average of 6.68%.
The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.19%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.26% | ||
| ROE | 0.96% | ||
| ROIC | 5.19% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
Looking at the Profit Margin, with a value of 0.34%, CRI is doing worse than 66.67% of the companies in the same industry.
CRI's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.46%, CRI perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
CRI's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 28.51%, CRI is doing worse than 80.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.46% | ||
| PM (TTM) | 0.34% | ||
| GM | 28.51% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRI is destroying value.
Compared to 1 year ago, CRI has more shares outstanding
The number of shares outstanding for CRI has been increased compared to 5 years ago.
The debt/assets ratio for CRI has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.23, we must say that CRI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.23, CRI is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
The Debt to FCF ratio of CRI is 131.84, which is on the high side as it means it would take CRI, 131.84 years of fcf income to pay off all of its debts.
CRI has a worse Debt to FCF ratio (131.84) than 73.33% of its industry peers.
A Debt/Equity ratio of 1.38 is on the high side and indicates that CRI has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.38, CRI is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 131.84 | ||
| Altman-Z | 1.23 |
ROIC/WACC0.8
WACC6.48%
2.3 Liquidity
CRI has a Current Ratio of 1.30. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.30, CRI is doing worse than 93.33% of the companies in the same industry.
A Quick Ratio of 0.86 indicates that CRI may have some problems paying its short term obligations.
With a Quick ratio value of 0.86, CRI is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 146.24%, which is quite impressive.
Measured over the past years, CRI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.59% on average per year.
Looking at the last year, CRI shows a small growth in Revenue. The Revenue has grown by 6.67% in the last year.
CRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.10% yearly.
EPS 1Y (TTM)146.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
CRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.48% yearly.
Based on estimates for the next years, CRI will show a small growth in Revenue. The Revenue will grow by 4.12% on average per year.
EPS Next Y46.67%
EPS Next 2Y52.98%
EPS Next 3Y32.48%
EPS Next 5YN/A
Revenue Next Year3.88%
Revenue Next 2Y5.15%
Revenue Next 3Y4.12%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 80.50, which means the current valuation is very expensive for CRI.
Based on the Price/Earnings ratio, CRI is valued a bit more expensive than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.47, CRI is valued quite expensively.
A Price/Forward Earnings ratio of 9.35 indicates a reasonable valuation of CRI.
80.00% of the companies in the same industry are more expensive than CRI, based on the Price/Forward Earnings ratio.
CRI is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.42, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.5 | ||
| Fwd PE | 9.35 |
4.2 Price Multiples
CRI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRI is cheaper than 73.33% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRI indicates a slightly more expensive valuation: CRI is more expensive than 73.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 75.14 | ||
| EV/EBITDA | 7.08 |
4.3 Compensation for Growth
CRI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CRI's earnings are expected to grow with 32.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.72
PEG (5Y)N/A
EPS Next 2Y52.98%
EPS Next 3Y32.48%
5. Dividend
5.1 Amount
CRI has a Yearly Dividend Yield of 1.32%. Purely for dividend investing, there may be better candidates out there.
CRI's Dividend Yield is slightly below the industry average, which is at 3.64.
Compared to an average S&P500 Dividend Yield of 2.44, CRI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.32% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CRI pays out 128.00% of its income as dividend. This is not a sustainable payout ratio.
DP128%
EPS Next 2Y52.98%
EPS Next 3Y32.48%
EPA:CRI (11/19/2025, 7:00:00 PM)
9.66
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners5.35%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap240.44M
Revenue(TTM)727.50M
Net Income(TTM)2.50M
Analysts75
Price Target13.09 (35.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.32% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP128%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-40.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.07%
Revenue NY rev (3m)-3.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.5 | ||
| Fwd PE | 9.35 | ||
| P/S | 0.33 | ||
| P/FCF | 75.14 | ||
| P/OCF | 10.28 | ||
| P/B | 0.92 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.08 |
EPS(TTM)0.12
EY1.24%
EPS(NY)1.03
Fwd EY10.7%
FCF(TTM)0.13
FCFY1.33%
OCF(TTM)0.94
OCFY9.73%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)1.72
PEG (5Y)N/A
Graham Number5.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.26% | ||
| ROE | 0.96% | ||
| ROCE | 7.08% | ||
| ROIC | 5.19% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 13.23% | ||
| OM | 6.46% | ||
| PM (TTM) | 0.34% | ||
| GM | 28.51% | ||
| FCFM | 0.44% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexgc growth 3Y-6.3%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 131.84 | ||
| Debt/EBITDA | 4.62 | ||
| Cap/Depr | 65.16% | ||
| Cap/Sales | 2.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30% | ||
| Profit Quality | 128% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 1.23 |
F-Score7
WACC6.48%
ROIC/WACC0.8
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)146.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y46.67%
EPS Next 2Y52.98%
EPS Next 3Y32.48%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year3.88%
Revenue Next 2Y5.15%
Revenue Next 3Y4.12%
Revenue Next 5YN/A
EBIT growth 1Y57.72%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year118.91%
EBIT Next 3Y41.15%
EBIT Next 5YN/A
FCF growth 1Y109.04%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y241.82%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%
COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ
What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.
Can you provide the valuation status for COMPAGNIE CHARGEURS INVEST?
ChartMill assigns a valuation rating of 4 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Fairly Valued.
What is the profitability of CRI stock?
COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.
What is the financial health of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.
Can you provide the expected EPS growth for CRI stock?
The Earnings per Share (EPS) of COMPAGNIE CHARGEURS INVEST (CRI.PA) is expected to grow by 46.67% in the next year.